×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Change in Definition of Core Basis in Financial Results News
Astellas Pharma
Astellas has been applying International Financial Reporting Standards to consolidated financial statements since FY2013, which ended March...
5 days ago
Earnings call: Astellas Pharma exceeds revenue forecast, faces profit dip By Investing.com
Investing.com
Astellas Pharma Inc. (ALPMY) reported a surpassing of its full-year revenue forecast for FY 2023, according to CEO Naoki Okamura during the...
17 hours ago
Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Simply Wall St
As you might know, Astellas Pharma Inc. ( TSE:4503 ) recently reported its annual numbers. It was not a great result...
1 day ago
Commitment to healthcare for local communities
Astellas Pharma
Based on our Raison D'être to “Contribute toward improving the health of people around the world through the provision of innovative and reliable...
5 days ago
Takeda, Astellas and Sumitomo Mitsui Banking Announce Master Agreement to Establish Joint Venture Company for ...
PR Newswire
PRNewswire/ -- Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK, President and CEO; Christophe Weber, "Takeda"), Astellas Pharma...
1 week ago
Takeda And Astellas Agree To Establish Joint Venture Company
Contract Pharma
New joint venture aims to cover the entire drug discovery process, spanning early drug discovery research through the inception of drug...
1 week ago
Astellas Pharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Simply Wall St
Astellas Pharma ( TSE:4503 ) Full Year 2024 Results Key Financial Results Revenue: JP¥1.60t (up 5.6% from FY 2023). Net...
3 days ago
New Digital Therapeutic for Heart Failure Patients on the Horizon
Astellas Pharma
New Digital Therapeutic for Heart Failure Patients on the Horizon · Improving disease management and aiming to positively impact clinical outcomes for patients...
1 month ago
Astellas Names Michael Petroutsas as Head of US Commercial USA - English
PR Newswire
PRNewswire/ -- Today, Astellas Pharma Inc. Chief Commercial Officer Claus Zieler has named Michael Petroutsas as Head, United States...
2 months ago
The past year for Astellas Pharma (TSE:4503) investors has not been profitable
Simply Wall St
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...
1 week ago